OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 99 filers reported holding OPHTHOTECH CORP in Q2 2014. The put-call ratio across all filers is 1.50 and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $13,935,000 | -39.2% | 310,554 | -47.3% | 1.50% | -44.7% |
Q3 2014 | $22,927,000 | +2.6% | 588,941 | +11.6% | 2.71% | +20.0% |
Q2 2014 | $22,337,000 | -64.0% | 527,941 | -69.6% | 2.26% | -49.2% |
Q1 2014 | $61,998,000 | +19.7% | 1,737,856 | +8.6% | 4.45% | -26.3% |
Q4 2013 | $51,775,000 | – | 1,600,455 | – | 6.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,103,981 | $44,734,000 | 25.02% |
Novo Holdings A/S | 4,910,487 | $198,973,000 | 20.56% |
JHL Capital Group LLC | 3,265,000 | $132,298,000 | 14.62% |
AlpInvest Partners B.V. | 111,519 | $4,519,000 | 8.90% |
Opaleye Management Inc. | 105,000 | $4,255,000 | 2.09% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 16,110 | $653,000 | 2.05% |
IMA Wealth, Inc. | 66,061 | $2,623,000 | 1.66% |
WILLIAM HARRIS INVESTORS INC | 143,022 | $5,795,000 | 1.64% |
Orbimed Advisors | 1,923,500 | $77,940,000 | 0.79% |
Overbrook Management Corp | 117,807 | $4,774,000 | 0.74% |